Trexquant Investment LP Kymera Therapeutics, Inc. Transaction History

Trexquant Investment LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$29.85 - $39.42 $1.34 Million - $1.77 Million	-44,787 Reduced 27.63%	117,328 $3.5 Million
Q1 2024 May 14, 2024	SELL	$22.9 - $43.57 $949,182 - $1.81 Million	-41,449 Reduced 20.36%	162,115 $6.52 Million
Q4 2023 Feb 09, 2024	BUY	$10.97 - $26.84 $2.23 Million - $5.46 Million	203,564 New	203,564 $5.18 Million
Q1 2022 May 13, 2022	SELL	$35.3 - $64.68 $369,026 - $676,164	-10,454 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$49.91 - $65.56 $521,759 - $685,364	10,454 New	10,454 $664,000
Q2 2021 Aug 12, 2021	SELL	$31.08 - $51.95 $198,290 - $331,441	-6,380 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$35.64 - $85.46 $227,383 - $545,234	6,380 New	6,380 $248,000

184

64.4M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.3B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.